Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;14(1):17-26.
doi: 10.1111/luts.12404. Epub 2021 Jul 28.

Holmium laser enucleation of the prostate: A truly size-independent method?

Alexander Tamalunas  1 , Thilo Westhofen  1 , Melanie Schott  1 , Patrick Keller  1 , Michael Atzler  1 , Christian G Stief  1 , Giuseppe Magistro  1
Affiliations

Holmium laser enucleation of the prostate: A truly size-independent method?

Alexander Tamalunas et al. Low Urin Tract Symptoms. 2022 Jan.

Erratum in

  • Corrigendum.
    [No authors listed] [No authors listed] Low Urin Tract Symptoms. 2022 Sep;14(5):405. doi: 10.1111/luts.12458. Low Urin Tract Symptoms. 2022. PMID: 36049886 No abstract available.

Abstract

Objectives: To evaluate the impact of prostate size on functional outcomes and perioperative morbidity, we analyzed patients undergoing holmium laser enucleation of the prostate (HoLEP) for lower urinary tract symptoms (LUTS). As LUTS secondary to benign prostatic obstruction (BPO) are a chronic progressive disease, prevalence and prostate size increase with age. HoLEP is a size-independent method for surgical treatment of LUTS/BPO and can be offered in medication-refractory patients with durable long-term results and reduced perioperative morbidity.

Methods: We retrospectively collected data of 852 patients who underwent HoLEP for LUTS secondary to BPO between 2014-2018. Patients were divided into group 1 (≤60 cc), group 2 (>60 < 120 cc), group 3 (≥120 cc). Perioperative parameters, safety and short-term functional outcomes were assessed and analyzed.

Results: Patients in group 3 were significantly older and showed a significantly higher median prostate-specific antigen level. Perioperative parameters, such as enucleation time and morcellation time significantly differed in favor of smaller prostate sizes, while enucleation and morcellation speed showed favorable results for larger prostate sizes. Larger prostates ≥120 cc showed a significantly higher postoperative drop in hemoglobin. However, patients did not differ in postoperative functional outcomes or Clavien-Dindo grade ≥II complications (4.8% of all patients [41/852]). There was no difference in perioperative complications between all groups (P = 0.760).

Conclusion: While larger prostates take significantly longer to operate on, postoperative functional outcomes show no difference between all sizes. In conclusion, HoLEP is a size-independent and effective method for surgical treatment of LUTS/BPO in prostates ≥30 cc.

Keywords: BPH; LUTS; benign prostatic enlargement; holmium laser enucleation of the prostate; medical treatment; prostate size.

PubMed Disclaimer

References

REFERENCES

    1. Roehrborn CG. Benign prostatic hyperplasia: an overview. Rev Urol. 2005;7(suppl 9):S3-S14.
    1. Roehrborn CG. Pathology of benign prostatic hyperplasia. Int J Impot Res. 2008;20(Suppl 3):S11-S18.
    1. Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108:1132-1138.
    1. Gazala S, Tul Y, Wagg A, Widder SL, Khadaroo RG, on behalf of the Acute Care and Emergency Surgery (ACES) GroupQuality of life and long-term outcomes of octo- and nonagenarians following acute care surgery: a cross sectional study. World J Emerg Surg. 2013;8:23.
    1. Loeb S, Kettermann A, Carter HB, Ferrucci L, Metter EJ, Walsh PC. Prostate volume changes over time: results from the Baltimore Longitudinal Study of Aging. J Urol. 2009;182:1458-1462.